Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding reduction during intertrochanteric fracture fixation
IRCT20200114046133N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intertrochanteric fracture comparing Tranexamic acid with Placebo control (2 arms). Primary endpoints: Intraoperative bleeding amount, Surgeon satisfaction and 5 more. Started Jan 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on IRCT20200114046133N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200114046133N1.